Photo Credit: Shah Junaid/VCCircle

Exclusive: India Life Sciences Fund II makes new pharma bet

19 May, 2017

Healthcare-focussed private equity fund India Life Sciences Fund II, which is advised by InvAscent India, has struck a new deal in the pharmaceuticals space taking the total number of investments from the fund to 11, two people privy to the development told VCCircle.


Leave Your Comment
EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

Madhav A Chanchani 4 years ago
Life sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund), which has just struck a deal with buyout giant KKR & Co to sell...
India Life Sciences Fund II raises $143M, to deploy $40M in 12 months

India Life Sciences Fund II raises $143M, to deploy $40M in 12 months

Shruti Ambavat 3 years ago
Life sciences-focused private equity fund manager InvAscent has raised Rs 875 crore ($143.2 million) to make a final close of its second fund India Life...
Exclusive: India Life Sciences Fund II invests in Biorad Medisys

Exclusive: India Life Sciences Fund II invests in Biorad Medisys

Joseph Rai 1 year ago
Healthcare-focused private equity fund India Life Sciences Fund II, which is advised by its investment manager InvAscent India, has invested in medical devices maker Biorad...
No Comments

Exclusive: India Life Sciences Fund II makes new pharma bet

Powered by WordPress.com VIP